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Closing the gap on DNA ligase 
Stewart Shuman
The crystal structure of T7 DNA ligase complexed with
ATP illuminates the mechanism of covalent catalysis by
a superfamily of nucleotidyl transferases that includes
the ATP-dependent polynucleotide ligases and the
GTP-dependent mRNA capping enzymes.
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The emerging connections between DNA repair pathways
and human cancers have fueled interest in the structures
of DNA repair enzymes, particularly proteins that recog-
nize and catalyze excision reactions at specific sites of
DNA damage. Yet, after the lesions have been removed
and any gaps have been filled in by DNA polymerases, it’s
up to the DNA ligases to restore the continuity of the
repaired DNA strand by converting nicks into phosphodi-
ester bonds. Nicks are potentially deleterious DNA
lesions that, if not corrected, may give rise to lethal double
strand breaks. Accordingly, the total loss of DNA ligase
function results in cell death. Whereas lower eukaryotes
(e.g., budding and fission yeast) appear to encode a single
essential DNA ligase, human cells contain multiple DNA
ligases encoded by separate genes [1]. Sequence compar-
isons suggest that a catalytic domain common to all
eukaryotic ligases is embellished by additional isozyme-
specific protein segments, which presumably confer
unique functional specificity in vivo. Despite early suc-
cesses in dissecting the biochemistry of ligation, there are
huge gaps in our understanding of the structural proper-
ties of the DNA ligases. That gap has now been narrowed
by the report of a crystal structure of the DNA ligase
encoded by bacteriophage T7 [2].    
The DNA ligases, including the T7 enzyme, were first
identified in 1967. The ATP-dependent ligases of eukary-
otes, eukaryotic viruses (vaccinia and African swine fever),
and bacterial viruses (T4 and T7) catalyze the joining 
of 5′-phosphate-terminated donor strands to 3′-hydroxyl-
terminated acceptor strands via a common pathway involv-
ing three sequential nucleotidyl transfer reactions [3]. In
the first step, nucleophilic attack on the a-phosphate of
ATP by the ligase results in liberation of pyrophosphate
(PPi) and formation of a covalent intermediate in which
AMP is linked to the enzyme via the e-amino group of a
lysine. The nucleotide is then transferred to the 5′ end of
the donor polynucleotide to form DNA–adenylate — an
inverted (5′)–(5′) pyrophosphate bridge structure, AppN.
Attack by the 3′ OH of the acceptor strand on the
DNA–adenylate joins the two polynucleotides and liber-
ates AMP. The NAD-dependent DNA ligases of eubacte-
ria catalyze strand joining by a similar pathway, except that
AMP is transferred to the protein from NAD, with con-
comitant release of nicotinamide mononucleotide (NMN)
rather than PPi. The elucidation of the role of ATP (or
NAD) in this reaction pathway is a biochemistry ‘classic’
[3], but too few contemporary users of DNA ligase appreci-
ate this elegant reaction mechanism. (A cynic might
attribute this to the use of pre-mixed ligation buffer that
accompanies commercially available enzyme.)
The ligase reaction is similar to that of mRNA-guanylyl
transferase, the enzyme responsible for 5′ capping of
eukaryotic mRNAs. RNA capping is a two-step nucleo-
tidyl-transfer reaction. In the first step, a lysine residue on
the enzyme attacks the a-phosphate of GTP to form a
covalent enzyme–GMP intermediate. The GMP is then
transferred to the 5′ diphosphate terminus of RNA. The
GpppN reaction product resembles the DNA–adenylate
intermediate in the ligase reaction. Like ATP-dependent
DNA ligase, mRNA guanylyl transferase is ubiquitous in
eukaryotes, and loss of capping activity is lethal.
The ATP-dependent ligases and GTP-dependent capping
enzymes make up a superfamily of covalent nucleotidyl
transferases [4]. This assertion is based on several lines of
evidence: mapping the adenylylation or guanylylation site
of several ligases and capping enzymes to a lysine residue
within a universally conserved KxDG element (motif I in
Fig. 1); the identification of five other sequence motifs
conserved in the same order and with nearly identical
spacing in the ligases and capping enzymes (motifs III,
IIIa, IV, V, and VI in Fig. 1); and the identification of cat-
alytically important residues within these conserved
motifs, by site-directed mutagenesis [5–8]. The sequence
similarity between the polynucleotide ligases and the
capping enzymes is limited to these segments, which sug-
gests a common core structure in which the motifs are
brought together at the enzyme’s active site. 
The co-crystal structure of the bacteriophage T7 DNA
ligase with bound ATP provides the first high-resolution
view of a member of this superfamily [2]. The structure,
shown in Figure 2, locates five of the phylogenetically con-
served motifs at the ligase active site! The disposition of
key residues relative to the nucleotide substrate illuminates
the mechanism of catalysis and the basis for nucleotide
specificity. In addition, the global structure raises interest-
ing questions about how ligase interacts with nucleic acid.
The T7 ligase, a 359-amino-acid polypeptide, is composed
of two domains with a groove running between them
(Fig. 2). Domain 1 includes conserved motifs I, III, IIIa,
and IV, which together make up the ATP-binding site.
Motifs III and IIIa are organized as an antiparallel b sheet
and are separated by a loop that is disordered in the
crystal. The 49-amino-acid segment of T7 DNA ligase
between III and IIIa is probably not important for enzyme
function, because motifs III and IIIa are separated by only
three or four residues in the capping enzymes encoded by
vaccinia virus or African swine fever virus (Fig. 1). Ligase
domain 2, which includes motif VI, consists of a twisted
antiparallel b sheet. Subramanya et al. [2] note that the
ligase domain 2 fold is present in several proteins that
bind single-strand DNA. Domains 1 and 2 are connected
by conserved motif V, which also contributes to the ATP-
binding pocket.
The co-crystal structure confirms and clarifies the catalytic
roles of several amino acid side chains defined as essential
by mutational analysis of vaccinia and yeast capping
enzymes and vaccinia and human DNA ligases [5–8]. To
begin with, it is comforting to note that the e-amino group
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Figure 1
Conserved sequence elements define a superfamily of covalent nucleotidyl
transferases. Six collinear sequence elements, designated motifs I, III, IIIa,
IV, V, and VI, are conserved in capping enzymes and ligases, as shown.
The amino-acid sequences are aligned for capping enzymes (CE) encoded
by vaccinia (VAC), Shope fibroma virus (SFV),  P. bursarium chlorella virus
(ChV), African swine fever virus (ASF), Sc. pombe (Sp) and S. cerevisiae
(Sc). Grouped below the capping enzymes are aligned sequences for the
DNA ligases (DNA) from VAC, SFV, fowlpox virus (FPV), Sc, Sp, human
ligase I (Hu1), human ligase 3 (Hu3), human ligase 4 (Hu4), Xenopus (Xe),
ASF, Desulfurolobus ambivalens (Dam), and bacteriophages T4 and T3
and T7. Also included is T4 RNA ligase. The number of intervening amino-
acid residues is indicated (-n-). Residues in the yeast or vaccinia virus
capping enzymes that were found by mutational analysis to be essential for
function are indicated by asterisks. Contacts between specific amino-acid
residues and the ATP cofactor in the crystal structure of T7 DNA ligase
are indicated below the T7 ligase sequence.
Figure 2
Structure of T7 DNA ligase with bound ATP.  The T7 ligase structure is
shown as a ribbon diagram with the conserved motifs in color: motif I
(yellow); motif III (green); motif IIIa (cyan); motif IV (red); motif V
(magenta); motif VI (blue). The bound ATP cofactor is colored orange. 
of the active-site lysine, Lys34, in the KxDG motif is
located near the a-phosphate of ATP, where it is poised to
form the covalent protein–AMP intermediate (Fig. 3).
Motif III contributes an essential glutamate residue,
Glu93, which hydrogen bonds to the ribose sugar of ATP.
Tyr149 in motif IIIa stacks on the purine base of the
nucleotide. Note that an aromatic amino acid is present at
an equivalent position in every other member of the
superfamily (Fig. 1). The first lysine residue in motif V,
Lys238, contacts the a-phosphate of ATP in the T7 ligase
crystal (Fig. 3). This residue is essential for the activity of
vaccinia DNA ligase [8]: alanine substitution at the equiv-
alent residue of the vaccinia capping enzyme reduces its
affinity for GTP by about a factor of 20 and elicits a similar
decrement in the rate of enzyme–GMP complex forma-
tion [5]. It seems likely that the conserved residues that
contact ATP in T7 DNA ligase will make similar contacts
with GTP in the case of the capping enzymes.
So what accounts for the exquisite specificity of ligase for
ATP and capping enzyme for GTP at the step of
enzyme–nucleoside monophosphate (NMP) formation? In
the T7 ligase structure, the 6-amino group of the adenine
ring is contacted by the main-chain carbonyl of residue 33
and by the side chain of Glu32 (Fig. 3). Among the ATP-
dependent ligases, the latter position is highly conserved
as glutamate, with occasional substitutions of an aspartate
or glutamine. However, this position is never occupied by
glutamate, aspartate or glutamine in the capping enzymes.
This raises the interesting question of whether the
capping enzymes could be rendered capable of utilizing
ATP if this position were mutated to a glutamate, or
whether removal of the glutamate moiety would relax the
nucleotide cofactor specificity of the ligases. 
The structure of ligase with bound ATP reflects the state
of the enzyme prior to the first chemical step of nucleotidyl
transfer. Because the ligation reaction can, in principle, be
arrested at discrete points along the reaction pathway, for
example by formation of the enzyme–adenylate in the
absence of DNA, and by trapping the DNA–adenylate
using gapped DNA substrates, the prospects seem favor-
able for achieving a crystallographic ‘snapshot’ of ligase in
action. It will be interesting to see if the disposition of the
nucleotide undergoes any change after formation of the
covalent protein–AMP adduct. Of particular relevance is
the location of bound nucleic acid on the enzyme.  Surface-
charge calculations for the T7 ligase indicate a large posi-
tive potential near the nucleotide-binding pocket; this
potential continues into the interdomain cleft (Fig. 4). The
T7 ligase crystal structure can accommodate a B-form
DNA duplex in the interdomain groove, the sides of which
are formed by the conserved motifs. I would speculate that
motif VI, which is within domain 2, is a component of the
nucleic-acid-binding site. Although there is as yet no direct
evidence for a specific biochemical role for motif VI in
catalysis, we have found that alanine substitution at four 
of the residues in motif VI of the yeast mRNA capping
enzyme (including a strictly conserved arginine) results in
a lethal phenotype in vivo (Fig. 1; L Deng and SS, unpub-
lished data). A critical question regarding nucleic-acid
binding asks how to account for the distinct binding speci-
ficities of the superfamily members. For example, the
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Figure 3
Close-up view of the ATP binding site. ATP is depicted in red. Amino
acid residues of the ATP ligase that contact ATP are shown. The color
scheme for the remaining residues corresponds to that in Figure 2.
Figure 4
Charge distribution over the surface of T7 ligase, suggesting a DNA
binding site in the interdomain groove. Positive potential is shown in
blue and negative potential in red. The bound ATP is green. (Figure
reproduced from [2], with permission.)
DNA ligases act exclusively on duplex nucleic acid,
whereas the T4 RNA ligase is active on single-stranded
RNA. Although RNA is clearly the physiological substrate
for capping enzyme, the enzyme’s ability to act on DNA
has not been evaluated as a diphosphate-terminated DNA
substrate is not easy to come by. 
In their paper, Subramanya et al. [2] cite unpublished
experiments that show that domain 2 by itself binds
tightly to duplex DNA. We are left wondering whether
T7 ligase displays any specificity for interaction with
nicked DNA, as has been described for the vaccinia DNA
ligase [9]. Vaccinia ligase discriminates at the DNA-
binding step between nicked DNAs, which are readily
resealed by the enzyme, and DNAs containing
1-nucleotide or 2-nucleotide gaps, which the vaccinia
ligase is incapable of rejoining. It is reasonable to invoke
some mechanism by which ligases would bind preferen-
tially to DNA sites where their action is required. This
property can be intrinsic to the ligase, or it may be con-
ferred by accessory proteins, present at sites where DNA
replication and repair are in progress, which recruit ligase
by protein–protein interactions [10].    
Now that we know something of the catalytic core of 
a covalent nucleotidyl transferase, the challenge is to
account for biological specificity in structural terms.
Obtaining high-resolution structures of an mRNA capping
enzyme and of T4 RNA ligase are the logical next steps.  
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